Apyx Medical (APYX) Competitors $1.44 +0.03 (+2.12%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends APYX vs. ICAD, CODX, PYPD, TELA, SGHT, SONX, PROF, SKIN, NVRO, and BWAYShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include iCAD (ICAD), Co-Diagnostics (CODX), PolyPid (PYPD), TELA Bio (TELA), Sight Sciences (SGHT), Sonendo (SONX), Profound Medical (PROF), Beauty Health (SKIN), Nevro (NVRO), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Apyx Medical vs. iCAD Co-Diagnostics PolyPid TELA Bio Sight Sciences Sonendo Profound Medical Beauty Health Nevro BrainsWay iCAD (NASDAQ:ICAD) and Apyx Medical (NASDAQ:APYX) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking. Does the media favor ICAD or APYX? In the previous week, iCAD had 4 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for iCAD and 0 mentions for Apyx Medical. iCAD's average media sentiment score of 0.61 beat Apyx Medical's score of 0.00 indicating that iCAD is being referred to more favorably in the media. Company Overall Sentiment iCAD Positive Apyx Medical Neutral Do analysts rate ICAD or APYX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iCAD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has more risk & volatility, ICAD or APYX? iCAD has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Do institutionals & insiders have more ownership in ICAD or APYX? 24.6% of iCAD shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.3% of iCAD shares are held by insiders. Comparatively, 16.8% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ICAD or APYX? iCAD received 150 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 62.13% of users gave iCAD an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformiCADOutperform Votes22862.13% Underperform Votes13937.87% Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Which has higher valuation and earnings, ICAD or APYX? iCAD has higher earnings, but lower revenue than Apyx Medical. iCAD is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiCAD$17.32M2.36-$4.85M-$0.13-11.85Apyx Medical$52.35M1.04-$18.71M-$0.83-1.74 Is ICAD or APYX more profitable? iCAD has a net margin of -17.81% compared to Apyx Medical's net margin of -58.59%. iCAD's return on equity of -15.65% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets iCAD-17.81% -15.65% -12.52% Apyx Medical -58.59%-137.98%-36.74% SummaryiCAD beats Apyx Medical on 11 of the 17 factors compared between the two stocks. Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$54.39M$4.51B$5.38B$8.84BDividend YieldN/A36.80%5.13%4.09%P/E Ratio-1.7426.03105.1417.83Price / Sales1.0446.931,233.15158.41Price / CashN/A53.5740.4136.29Price / Book4.825.947.096.50Net Income-$18.71M$13.99M$119.65M$226.22M7 Day Performance14.68%3.27%2.25%4.03%1 Month Performance30.18%4.64%-2.33%4.92%1 Year Performance-37.72%47.15%33.98%29.30% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical1.4212 of 5 stars$1.45+2.1%N/A-37.7%$54.39M$52.35M-1.74270Gap UpICADiCAD0.5727 of 5 stars$1.56+1.3%N/A+18.5%$41.40M$17.32M-11.8567Analyst UpgradeCODXCo-Diagnostics4.3866 of 5 stars$1.05-1.4%$1.50+43.5%-19.8%$33.37M$6.81M-0.76100PYPDPolyPid2.8543 of 5 stars$3.50+2.0%$12.00+242.9%-11.0%$16.80MN/A-0.4480Positive NewsGap DownHigh Trading VolumeTELATELA Bio3.4395 of 5 stars$2.93+1.4%$9.25+215.7%-37.9%$115.41M$58.45M-1.71120SGHTSight Sciences2.4237 of 5 stars$4.04+7.4%$5.50+36.1%+60.4%$205.07M$81.06M-3.69210Gap UpSONXSonendoN/A$2.23+3.2%N/A+1,724.0%$186.45M$44.40M-4.96250Positive NewsGap UpPROFProfound Medical1.7124 of 5 stars$7.56+0.5%$13.75+81.9%-26.6%$186.43M$7.20M-5.61150SKINBeauty Health2.962 of 5 stars$1.43+2.9%$2.55+78.3%-36.2%$177.35M$398M0.001,030Positive NewsNVRONevro2.7107 of 5 stars$4.61+5.7%$9.10+97.4%-72.2%$172.75M$419.15M-2.351,215Analyst UpgradeBWAYBrainsWay4.1112 of 5 stars$9.91+0.7%$13.17+32.9%+81.5%$165.30M$31.78M98.41120 Related Companies and Tools Related Companies ICAD Competitors CODX Competitors PYPD Competitors TELA Competitors SGHT Competitors SONX Competitors PROF Competitors SKIN Competitors NVRO Competitors BWAY Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:APYX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
